Qube Research & Technologies Ltd
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1729829
LONDON, X0
Position in REGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$138,180,828
+$73,775,103 QoQ
Shares Held
221,607
+165.8% QoQ
Ownership
0.215%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#63
of 1,322 holders
Holding Since
Sep 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Derivatives in REGN
reported options exposure · as of Jun 30, 2026CallValue
$3,304,762
CallShares
5,300
PutValue
$2,618,868
PutShares
4,200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Qube Research & Technologies Ltd holds $2,443,068,185 across 169 Biotechnology names. REGN ranks #3 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
798,715 | $240,437,176 | |
| 2 | INSM |
INSMED Inc
|
1,682,334 | $179,370,451 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
221,607 | $138,180,828 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
3,454,496 | $122,254,613 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
426,336 | $104,354,262 | |
| 6 | APGE |
Apogee Therapeutics, Inc.
|
659,678 | $87,559,060 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,443,230 | $81,989,896 | |
| 8 | RPRX |
Royalty Pharma plc
|
1,412,112 | $79,177,119 |
All Filings in REGN
Export CSV
41 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,304,762 | 5,300 | Call | Sole | 2026-08-14 | |
| 2026-06-30 | $138,180,828 | 221,607 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $2,618,868 | 4,200 | Put | Sole | 2026-08-14 | |
| 2026-03-31 | $5,408,480 | 7,000 | Put | Sole | 2026-05-15 | |
| 2026-03-31 | $64,405,725 | 83,358 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $6,490,176 | 8,400 | Call | Sole | 2026-05-15 | |
| 2025-12-31 | $19,065,189 | 24,700 | Put | Sole | 2026-02-17 | |
| 2025-12-31 | $109,746,792 | 142,183 | Shares | Sole | 2026-02-17 | |
| 2025-12-31 | $22,384,230 | 29,000 | Call | Sole | 2026-02-17 | |
| 2025-09-30 | $24,177,610 | 43,000 | Put | Sole | 2025-11-14 | |
| 2025-09-30 | $24,683,653 | 43,900 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $308,536,666 | 548,734 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $328,639,500 | 625,980 | Shares | Sole | 2025-08-14 | |
| 2025-06-30 | $22,627,500 | 43,100 | Put | Sole | 2025-08-14 | |
| 2025-06-30 | $20,842,500 | 39,700 | Call | Sole | 2025-08-14 | |
| 2025-03-31 | $5,010,417 | 7,900 | Call | Sole | 2025-05-15 | |
| 2025-03-31 | $445,795,193 | 702,892 | Shares | Sole | 2025-05-15 | |
| 2025-03-31 | $34,946,073 | 55,100 | Put | Sole | 2025-05-15 | |
| 2024-12-31 | $1,780,825 | 2,500 | Call | Sole | 2025-02-14 | |
| 2024-12-31 | $17,665,784 | 24,800 | Put | Sole | 2025-02-14 | |
| 2024-12-31 | $314,603,393 | 441,654 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $6,097,192 | 5,800 | Put | Sole | 2024-11-14 | |
| 2024-09-30 | $159,755,891 | 151,969 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $20,284,879 | 19,300 | Put | Sole | 2024-08-14 | |
| 2024-06-30 | $203,845,166 | 193,948 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $91,725,297 | 95,300 | Put | Sole | 2024-05-14 | |
| 2024-03-31 | $150,002,140 | 155,848 | Shares | Sole | 2024-05-14 | |
| 2024-03-31 | $2,502,474 | 2,600 | Call | Sole | 2024-05-14 | |
| 2023-12-31 | $4,040,134 | 4,600 | Put | Sole | 2024-02-13 | |
| 2023-12-31 | $150,507,287 | 171,364 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $4,726,259 | 5,743 | Shares | Sole | 2023-11-13 | |
| 2023-09-30 | $14,237,208 | 17,300 | Put | Sole | 2023-11-13 | |
| 2023-03-31 | $3,713,126 | 4,519 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $76,967,831 | 106,679 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $5,292,588 | 7,683 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $48,916,007 | 82,750 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $6,725,784 | 9,630 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $13,047,203 | 20,660 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $22,176,821 | 36,645 | Shares | Sole | 2021-11-12 | |
| 2020-12-31 | $12,861,354 | 26,622 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $13,138,036 | 23,470 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||